DR. MELVYN ANHALT
MDReal-Time HydratedLIFETIME INDUSTRY VALUE
$504
2021 – 2024 Cumulative
Conflict of Interest Analysis
Dr. ANHALT is a verified Urology practitioner based in HOUSTON, TX.
Between 2021 and 2024, Dr. ANHALT had an overall industry promotional and research financial footprint of $504 as recorded in the federal CMS Open Payments database.
- $504 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
- $0 was allocated to sponsored clinical trials and medical research activities.
Dr. ANHALT's primary funding source is CARDIOVASCULAR SYSTEMS, which accounts for $116 (representing 23% of overall industry footprint).
Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.
Payout Trend Over Time
General Payments
Research Funding
Top Funding Entities
Pharmaceutical & Device Manufacturers making direct payments
Rank 1
$116
23%Rank 2
$71
14.2%Rank 3
$68
13.4%General payments include consulting honoraria, promotional speaking fees, meals, travel, educational materials, and entertainment offsets.
PROMOTIONAL COUNT
Active
ESTIMATED COMPLIANCE RISK
Standard
Itemized Transaction Archives
Direct live query to Socrata CMS Open Payments API (Bypasses local DB)
Year:
2024
2024
2023
2022
2021
Click "Load Live Logs" to query the federal Open Payments registry directly.
Frequently Asked Questions
Answers compiled using federal transparency disclosure records under the Sunshine Act.